Drawing for WELLSENSE

USPTO serial 90546847

WELLSENSE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
HESIK, APRIL ANNE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with WELLSENSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Heather A. Antoine

Heather A. Antoine Stubbs Alderton & Markiles, LLP15260 Ventura Blvd., 20th FloorSherman Oaks, CA 91403United States

Goods and services

ClassDescriptionStatusFirst use
005Food supplements; dietary food supplements; health food supplements; nutritional supplements; powdered nutritional supplemental drink mix containing proteinACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 7, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 7, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 29, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 28, 2024EX5GSOU EXTENSION 5 GRANTED—
May 28, 2024EXT5SOU EXTENSION 5 FILED—
May 28, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 30, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 29, 2023EX4GSOU EXTENSION 4 GRANTED—
Nov 29, 2023EXT4SOU EXTENSION 4 FILED—
Nov 29, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 19, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 18, 2023EX3GSOU EXTENSION 3 GRANTED—
May 17, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 15, 2023EXT3SOU EXTENSION 3 FILED—
May 15, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 29, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 27, 2022EX2GSOU EXTENSION 2 GRANTED—
Sep 27, 2022EXT2SOU EXTENSION 2 FILED—
Sep 27, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 4, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 2, 2022EX1GSOU EXTENSION 1 GRANTED—
Jun 2, 2022EXT1SOU EXTENSION 1 FILED—
Jun 2, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 24, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 24, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 24, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 24, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 24, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 21, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 26, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 26, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 6, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 21, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 21, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Sep 21, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 21, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 21, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 20, 2021DOCKASSIGNED TO EXAMINER—
May 27, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 1, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance